Open Access<p>Nalbuphine versus Midazolam as an Adjuvant to Intrathecal Bupivacaine for Postoperative Analgesia in Patients Undergoing Cesarean Section</p>
Author(s) -
Olfat Abdelmoniem Ibrahem Amin,
Mohamed Abdel-Moniem Ibrahem,
Dina Abdelhameed Elsadek Salem
Publication year - 2020
Publication title -
journal of pain research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 49
ISSN - 1178-7090
DOI - 10.2147/jpr.s242545
Subject(s) - medicine , nalbuphine , anesthesia , bupivacaine , analgesic , midazolam , sedation , saline , adverse effect , dexmedetomidine , intrathecal , surgery , opioid , receptor
Adding adjuvants to intrathecal hyperbaric bupivacaine provides long analgesic duration with less adverse effects. The aim of this study was to compare intrathecal nalbuphine versus midazolam in patients undergoing cesarean section.